Based on the RNA data, we assigned a transcriptionally compatible ALL subtype to 207 patients (41% of 448) —these are conceptually similar to the Ph-like and ETV6::RUNX1-like gene expression profiles from previous studies. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.